Synthesis and antibacterial activity of some novel 6-(1H-benz[d] imidazol-2-yl)-8-(5-nitro-2-furyl)-3-(4-pyridyl)-7,8-dihydro[1,2,4] triazolo[3,4-b][1,3,4]thiadiazepines

Chemical and Pharmaceutical Bulletin

Volumn 58, Issue 8, 2010, Pages 1081-1084

  Reddy, Vanga Malla ^a   Reddy, Kunduru Ravinder ^a  

^a KAKATIYA UNIVERSITY   (India)

Author keywords

Antimicrobial activity; Benzimidazole; Thiadiazepine; Triazole

Indexed keywords

6 (1H BENZ[D]IMIDAZOL 2 YL) 8 (5 NITRO 2 FURYL) 3 (4 PYRIDYL) 7,8 DIHYDRO[1,2,4]TRIAZOLO[3,4 B][1,3,4]THIADIAZEPINE; 6 (6 CHLORO 1H BENZ[D]IMIDAZOL 2 YL) 8 (5 NITRO 2 FURYL) 3 (4 PYRIDYL) 7,8 DIHYDRO[1,2,4]TRIAZOLO[3,4 B][1,3,4]THIADIAZEPINE; 6 (6 METHYL 1H BENZ[D]IMIDAZOL 2 YL) 8 (5 NITRO 2 FURYL) 3 (4 PYRIDYL) 7,8 DIHYDRO[1,2,4]TRIAZOLO[3,4 B][1,3,4]THIADIAZEPINE; 6 (6 NITRO 1H BENZ[D]IMIDAZOL 2 YL) 8 (5 NITRO 2 FURYL) 3 (4 PYRIDYL) 7,8 DIHYDRO[1,2,4]TRIAZOLO[3,4 B][1,3,4]THIADIAZEPINE; ANTIINFECTIVE AGENT; DIAZEPINE DERIVATIVE; FLUCONAZOLE; IMIDAZOLE DERIVATIVE; NITROFURAN DERIVATIVE; PENICILLIN G; PYRIDINE DERIVATIVE; STREPTOMYCIN; TRIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BACILLUS SUBTILIS; BACTERIAL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; ESCHERICHIA COLI; FUSARIUM OXYSPORUM; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; INFRARED SPECTROSCOPY; KLEBSIELLA PNEUMONIAE; MASS SPECTROMETRY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; STAPHYLOCOCCUS AUREUS; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; ASPERGILLUS NIGER; BACILLUS SUBTILIS; BENZIMIDAZOLES; ESCHERICHIA COLI; FUSARIUM; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; STAPHYLOCOCCUS AUREUS; THIAZEPINES; TRIAZOLES;

EID: 77955387239     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.58.1081     Document Type: Article

References (40)

1. Porcari A. R., Devivar R. V., Kucera L. S., Drach J. C., Townsend L. B., J. Med. Chem., 41, 1252-1262 (1998).
2. Roth Y., Morningstar M. L., Boyer P. L., Hughes S. H., Buckheitjr R. W., Michejda C. J., J. Med. Chem., 40, 4199-4207 (1997).
3. Migawa M. T., Girardet J. L., Walker J. A., Koszalka G. W., Chamberlain S. D., Drach J. C., Townsend L. B., J. Med. Chem., 41, 1242-1251 (1998).
4. Tamm I., Sehgal P. B., Adv. Virus Res., 22, 187-258 (1978).
5. Tamm I., Science, 126, 1235-1236 (1957).
6. Czarny A., Wilson W. D., Boykin D. W., J. Heterocycl. Chem., 33, 1393-1397 (1996).
7. Reddy G. V., Rao V. V. V. N. S. R., Narsaiah B., Rao B. P. S., Synth. Commun., 32, 2467-2476 (2002).
8. Chakrabarty M., Karmakar S., Mukherji A., Arima S., Harigaya Y., Heterocycles, 68, 967-974 (2006).
9. Gogoi P., Konwar D., Tetrahedron Lett., 47, 79-82 (2006).
10. Randall L. O., "Psychopharmacological Agents," ed. by Gordon M., Academic Press, New York, 1974, pp. 175-281.
11. Fryer R. I., "Comprehensive Heterocyclic Chemistry," ed. by Taylor E. C., Wiley, New York, 1991, p. 50.
12. Devi T. K., Achaiah G., Reddy V. M., J. Ind. Chem. Soc., 65, 567-570 (1988).
13. Narayana B., Vijaya Raj K. K., Ashalatha B. V., Suchetha Kumari N., Eur. J. Med. Chem., 41, 417-422 (2006).
14. Hussenether T., Hubner H., Gmeiner P., Troschutz, Bioorg. Med. Chem., 12, 2625-2637 (2004).
15. Roma G., Grossi G. C., Di Braccio M., Ghia., Mattioli F., Eur. J. Med. Chem., 26, 489-496 (1991).
16. Kavali J. R., Badami B. V., Il Farmaco, 55, 406-409 (2000).
17. Di Braccio M., Grossi G. C., Roma G., Vargiu L., Mura M., Marongiu M. E., Eur. J. Med. Chem., 36, 935-949 (2001).
18. Kumar R., Joshi Y. C., Arkivoc, 2007, 142-149 (2007).
19. Kamal A., Shankaraiah N., Prabhakar S., Reddy C. R., Markandeya N., Laxma K., Devaiah X., Bioorg. Med. Chem. Lett., 18, 2434-2439 (2008).
20. Kosychova L., Stumbreviciute Z., Pleckaitiene L., Janciene R., Puodziunaite B. D., Chem. Heterocycl. Comp., 40, 811-815 (2004).
21. Janciene R., Vektariene A., Stumbreviciute Z., Kochychova L., Klimavicius A. A., Heteroatom. Chem., 15, 363-368 (2004).
22. Kosychova L., Pleckaitiene L., Staniulyte Z., Janciene R., Palaima A., Puodziunaite B. D., Arkivoc, 2006, 158-164 (2006).
23. Che X., Zheng L., Dang Q., Bai X., Tetrahedron, 62, 2563-2568 (2006).
24. Terret N. K., Bojanic D., Merson J. R., Stephenson P. T., Bioorg. Med. Chem. Lett., 2, 1745-1750 (1992).
25. Sanghetti J. N., Kokare N. D., Shinde D. B., Chinese Chem. Lett., 18, 1305-1308 (2007).
26. Kusanur Raviraj A., Ghate M., Kulkarni M. V., J. Chem. Sci., 116, 265-127 (2004).
27. Kidwai M., Ruby M. K., Venkataramanan R., Chem. Heterocycl. Comp., 40, 631-634 (2004).
28. Sanna P., Carta A., Nikookar M. E., Eur. J. Med. Chem., 35, 535-543 (2000).
29. Kopanska K., Najda A., Zebrowska J., Chomicz L., Piekarczyk J., Myjak P., Bretner M., Bioorg. Med. Chem., 12, 2617-2624 (2004).
30. Boido A., Vazzana I., Mattioli F., Sparatore F., Il Farmaco, 58, 33-44 (2003).
31. Biagi B., Calderone V., Giorgi I., Livi O., Scartoni V., Baragatti B., Martinotti E., Il Farmaco, 56, 841-849 (2001).
32. Katritzky A. R., Lan X., Yang J. Z., Denisko O. V., Chem. Rev., 98, 409-548 (1998).
33. Reddy A. M., Reddy R. R., Reddy V. V., Reddy A. M., Reddy R. R., Reddy V. M., Ind. J. Pharm. Sci., 53, 229-232 (1991).
34. Achaiah G., Reddy V. M., Reddy V. M., Ind. J. Pharm. Sci., 53, 253-255 (1991).
35. Suresh T., Patnaik S., Chakravarthy A. K., Reddy V. M., J. Pharm. Res., 5, 116-121 (2006).
36. Suresh T., Swamy S. K., Reddy V. M., Ind. J. Chem., 46B, 115-125 (2007).
37. Suresh T., Srinivas Naik A., Reddy V. M., Ind. J. Heterocycl. Chem., 17, 97-101 (2007).
38. Gajbhiya A., Reddy V. M., Achaiah G., Ind. J. Pharm. Sci., 70, 118-120 (2008).
39. Laddi U. V., Talwar M. B., Desai S. R., Bennur R. S., Bennur S. C., Ind. J. Chem., 40B, 828-832 (2001).
40. Barry A. L., "The Anti-microbial Susceptibility Test," Principle and Practice, ed. by Illus-lea and Febiger, Philadelphia, PA, U.S.A., 1976, p. 180.